Heart Failure Clinical Trial

Comparing the Effects of Conivaptan and Diuretics on Plasma Neurohormones and Renal Blood Flow in Patients With Chronic Congestive Heart Failure

Summary

The purpose of the study is to compare the effects of conivaptan and diuretics on renal blood flow and neurohormones.

View Full Description

Full Description

To define the hemodynamic, neurohormonal and renal responses to intravenous conivaptan in patients with chronic stable heart failure (HF), and compare these responses to those after intravenous furosemide.
To define the hemodynamic, neurohormonal and renal responses to the combination of the two drugs (conivaptan and furosemide).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Have a diagnosis of chronic congestive heart failure of any etiology
Be between 18-80 years of age
Able to provide consent
Have a documented left ventricular ejection fraction within the last year of < 40%
On a stable dose (no changes within 2 weeks) of 40 mg or greater daily dose of furosemide or its equivalent
On standard HF therapy medications (ACEI or ARB and beta-blocker unless contraindicated)
Have an estimated glomerular filtration rate (GFR) of 30 ml/minute or greater (based on the Cockcroft Gault calculation)
Have a hemoglobin of > 10 grams/dl
Have a negative urine pregnancy for women of childbearing years only

Exclusion Criteria:

Acute coronary syndrome within 1 month
Systolic blood pressure less than or equal to 90 mmHg at time of enrollment
Poor peripheral venous access
Severe concomitant disease which deemed by the investigator would render them unsuitable for this trial
Allergy or contraindication to the use of iothalamate, PAH - Specifically any allergies to iodine or iodine containing products, history of asthma and hay fever which deemed by the investigator would render them unsuitable for this trial

Study is for people with:

Heart Failure

Estimated Enrollment:

8

Study ID:

NCT00924014

Recruitment Status:

Unknown status

Sponsor:

Hennepin County Medical Center, Minneapolis

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Hennepin county Medical Center
Minneapolis Minnesota, 55404, United States More Info
Steven R Goldsmith, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

8

Study ID:

NCT00924014

Recruitment Status:

Unknown status

Sponsor:


Hennepin County Medical Center, Minneapolis

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider